MedTrace Logo

Insomnia in Primary Care

NCT06575998 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 485

Last updated 2026-03-30

No results posted yet for this study

Summary

The goal of this clinical trial is to learn if training primary care providers on treatment of insomnia can improve insomnia symptoms in patients. Researchers will compare insomnia symptoms of patients receiving care from trained practices with patients receiving care from control practices (providing care-as-usual), to see if the training helps to provide improved insomnia care. Participants will be asked to complete four questionnaires and some participants will be invited for an insomnia consultation in primary care by their primary care providers (PCP).

Conditions

Interventions

OTHER

Training

A 4-hour training for PCPs consisting of an onsite training, an e-learning and a webinar on the treatment of insomnia.

OTHER

Pro-active identification

Pro-active identification of patients with clinical insomnia symptoms. Patients receiving care from the participating practices will be asked to fill-out the Insomnia Severity Index (ISI).The ISI is used to identify patients with clinical insomnia symptoms in the general practice. Trained practices will receive feedback on the ISI for half of the patients with clinical symptoms according to the ISI.

Sponsors & Collaborators

  • Leiden University Medical Center

    lead OTHER

Principal Investigators

  • Dennis O. Mook-Kanamori · Leiden University Medical Center (LUMC)

  • Rutger A. Middenburg · Leiden University Medical Center (LUMC)

  • Mattijs E. Numans · Leiden University Medical Center (LUMC)

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-09-12
Primary Completion
2026-03-13
Completion
2026-03-13

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06575998 on ClinicalTrials.gov